Clinical Trial Update: GSK BHR Study (Sont) [Phase 4]

View source ↗

Summary

A Phase 4 asthma trial sponsored by GlaxoSmithKline (the GSK BHR study) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED